Who Pays My Doctor?
›
Clay Guynn, D.O.
Healthcare provider profile · identity verified
Clay Guynn, D.O.
Allopathic & Osteopathic Physicians|Physical Medicine & Rehabilitation · LEXINGTON, KY · NPI 1699180398
Profile state: payments and partd
Open Payments: 2025
Medicare Part D: 2024
Last identity check: 2026-08-10
Page data build: 2026-08-12
Verified facts
What the public records show
CMS Open Payments records show Clay Guynn, D.O. received $75,081.83 in general payments during 2025 across 239 reported records.
Pacira Pharmaceuticals Incorporated accounted for 99.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 9 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
General Payments
$75,081.83
239 reported records · 6 companies
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
Reported company Canonical company Amount Share Records Year
Pacira Pharmaceuticals Incorporated
Unresolved — no canonical attribution shown
$74,576.12 99.3% 227 2025
Avanos Medical
Unresolved — no canonical attribution shown
$157.09 0.2% 2 2025
Bioventus LLC
Unresolved — no canonical attribution shown
$129.62 0.2% 4 2025
VERTEX PHARMACEUTICALS INCORPORATED
Unresolved — no canonical attribution shown
$116.69 0.2% 4 2025
Abbott Laboratories
Unresolved — no canonical attribution shown
$71.47 0.1% 1 2025
ABBVIE INC.
Unresolved — no canonical attribution shown
$30.84 0.0% 1 2025
What were the payments for?
Payment categories
Category Amount Records
Consulting Fee $29,862.30 34 Honoraria $24,160.00 8 Travel and Lodging $15,898.94 74 Food and Beverage $5,149.77 121 Education $10.82 2
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Reported product Type Reported company Related amount* Records Year
Iovera Normalized: iovera Device
Pacira Pharmaceuticals Incorporated
$71,875.10
220
2025
Source payment records
2025-01-14 · Pacira Pharmaceuticals Incorporated · $155.00 ·
Open Payments source
2025-01-21 · Pacira Pharmaceuticals Incorporated · $1,298.76 ·
Open Payments source
2025-01-22 · Pacira Pharmaceuticals Incorporated · $113.83 ·
Open Payments source
2025-01-23 · Pacira Pharmaceuticals Incorporated · $33.90 ·
Open Payments source
2025-01-24 · Pacira Pharmaceuticals Incorporated · $28.76 ·
Open Payments source
2025-01-30 · Pacira Pharmaceuticals Incorporated · $155.00 ·
Open Payments source
2025-01-31 · Pacira Pharmaceuticals Incorporated · $161.41 ·
Open Payments source
2025-01-31 · Pacira Pharmaceuticals Incorporated · $219.38 ·
Open Payments source
2025-02-01 · Pacira Pharmaceuticals Incorporated · $33.37 ·
Open Payments source
2025-02-01 · Pacira Pharmaceuticals Incorporated · $13.69 ·
Open Payments source
2025-02-01 · Pacira Pharmaceuticals Incorporated · $53.12 ·
Open Payments source
2025-02-01 · Pacira Pharmaceuticals Incorporated · $642.96 ·
Open Payments source
2025-02-11 · Pacira Pharmaceuticals Incorporated · $35.51 ·
Open Payments source
2025-02-11 · Pacira Pharmaceuticals Incorporated · $31.00 ·
Open Payments source
2025-02-11 · Pacira Pharmaceuticals Incorporated · $66.20 ·
Open Payments source
2025-02-11 · Pacira Pharmaceuticals Incorporated · $3,720.00 ·
Open Payments source
2025-02-11 · Pacira Pharmaceuticals Incorporated · $7.16 ·
Open Payments source
2025-02-11 · Pacira Pharmaceuticals Incorporated · $7.49 ·
Open Payments source
2025-02-11 · Pacira Pharmaceuticals Incorporated · $6.44 ·
Open Payments source
2025-02-18 · Pacira Pharmaceuticals Incorporated · $62.00 ·
Open Payments source
2025-02-26 · Pacira Pharmaceuticals Incorporated · $117.60 ·
Open Payments source
2025-02-28 · Pacira Pharmaceuticals Incorporated · $92.33 ·
Open Payments source
2025-03-13 · Pacira Pharmaceuticals Incorporated · $155.00 ·
Open Payments source
2025-03-18 · Pacira Pharmaceuticals Incorporated · $155.00 ·
Open Payments source
2025-03-18 · Pacira Pharmaceuticals Incorporated · $232.50 ·
Open Payments source
2025-04-01 · Pacira Pharmaceuticals Incorporated · $155.00 ·
Open Payments source
2025-04-01 · Pacira Pharmaceuticals Incorporated · $155.00 ·
Open Payments source
2025-04-04 · Pacira Pharmaceuticals Incorporated · $20.97 ·
Open Payments source
2025-04-15 · Pacira Pharmaceuticals Incorporated · $155.00 ·
Open Payments source
2025-04-15 · Pacira Pharmaceuticals Incorporated · $232.50 ·
Open Payments source
2025-04-23 · Pacira Pharmaceuticals Incorporated · $332.98 ·
Open Payments source
2025-04-23 · Pacira Pharmaceuticals Incorporated · $301.39 ·
Open Payments source
2025-04-23 · Pacira Pharmaceuticals Incorporated · $604.00 ·
Open Payments source
2025-04-23 · Pacira Pharmaceuticals Incorporated · $92.70 ·
Open Payments source
2025-04-24 · Pacira Pharmaceuticals Incorporated · $30.62 ·
Open Payments source
2025-04-29 · Pacira Pharmaceuticals Incorporated · $88.87 ·
Open Payments source
2025-04-30 · Pacira Pharmaceuticals Incorporated · $11.78 ·
Open Payments source
2025-05-01 · Pacira Pharmaceuticals Incorporated · $31.50 ·
Open Payments source
2025-05-01 · Pacira Pharmaceuticals Incorporated · $32.00 ·
Open Payments source
2025-05-01 · Pacira Pharmaceuticals Incorporated · $34.02 ·
Open Payments source
2025-05-01 · Pacira Pharmaceuticals Incorporated · $3,410.00 ·
Open Payments source
2025-05-01 · Pacira Pharmaceuticals Incorporated · $465.00 ·
Open Payments source
2025-05-01 · Pacira Pharmaceuticals Incorporated · $19.37 ·
Open Payments source
2025-05-01 · Pacira Pharmaceuticals Incorporated · $45.17 ·
Open Payments source
2025-05-01 · Pacira Pharmaceuticals Incorporated · $20.93 ·
Open Payments source
2025-05-01 · Pacira Pharmaceuticals Incorporated · $9.05 ·
Open Payments source
2025-05-01 · Pacira Pharmaceuticals Incorporated · $13.60 ·
Open Payments source
2025-05-02 · Pacira Pharmaceuticals Incorporated · $69.81 ·
Open Payments source
2025-05-02 · Pacira Pharmaceuticals Incorporated · $472.96 ·
Open Payments source
2025-05-02 · Pacira Pharmaceuticals Incorporated · $40.00 ·
Open Payments source
2025-05-02 · Pacira Pharmaceuticals Incorporated · $174.38 ·
Open Payments source
2025-05-03 · Pacira Pharmaceuticals Incorporated · $48.71 ·
Open Payments source
2025-05-07 · Pacira Pharmaceuticals Incorporated · $18.45 ·
Open Payments source
2025-05-08 · Pacira Pharmaceuticals Incorporated · $35.92 ·
Open Payments source
2025-05-12 · Pacira Pharmaceuticals Incorporated · $5.41 ·
Open Payments source
2025-05-12 · Pacira Pharmaceuticals Incorporated · $5.41 ·
Open Payments source
2025-05-15 · Pacira Pharmaceuticals Incorporated · $155.00 ·
Open Payments source
2025-05-27 · Pacira Pharmaceuticals Incorporated · $1,240.00 ·
Open Payments source
2025-05-27 · Pacira Pharmaceuticals Incorporated · $155.00 ·
Open Payments source
2025-06-19 · Pacira Pharmaceuticals Incorporated · $155.00 ·
Open Payments source
2025-07-02 · Pacira Pharmaceuticals Incorporated · $2,790.00 ·
Open Payments source
2025-07-02 · Pacira Pharmaceuticals Incorporated · $16.50 ·
Open Payments source
2025-07-02 · Pacira Pharmaceuticals Incorporated · $66.36 ·
Open Payments source
2025-07-02 · Pacira Pharmaceuticals Incorporated · $15.97 ·
Open Payments source
2025-07-02 · Pacira Pharmaceuticals Incorporated · $83.82 ·
Open Payments source
2025-07-02 · Pacira Pharmaceuticals Incorporated · $577.97 ·
Open Payments source
2025-07-03 · Pacira Pharmaceuticals Incorporated · $102.30 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $38.06 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $7,425.00 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $13.06 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $19.37 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $43.00 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $24.50 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $18.48 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $47.21 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $66.36 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $15.52 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $11.00 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $60.00 ·
Open Payments source
2025-07-12 · Pacira Pharmaceuticals Incorporated · $175.93 ·
Open Payments source
2025-08-04 · Pacira Pharmaceuticals Incorporated · $150.00 ·
Open Payments source
2025-08-12 · Pacira Pharmaceuticals Incorporated · $77.50 ·
Open Payments source
2025-08-12 · Pacira Pharmaceuticals Incorporated · $155.00 ·
Open Payments source
2025-08-13 · Pacira Pharmaceuticals Incorporated · $42.55 ·
Open Payments source
2025-08-14 · Pacira Pharmaceuticals Incorporated · $114.13 ·
Open Payments source
2025-09-04 · Pacira Pharmaceuticals Incorporated · $620.00 ·
Open Payments source
2025-09-09 · Pacira Pharmaceuticals Incorporated · $506.98 ·
Open Payments source
2025-09-09 · Pacira Pharmaceuticals Incorporated · $121.86 ·
Open Payments source
2025-09-09 · Pacira Pharmaceuticals Incorporated · $55.00 ·
Open Payments source
2025-09-09 · Pacira Pharmaceuticals Incorporated · $264.42 ·
Open Payments source
2025-09-11 · Pacira Pharmaceuticals Incorporated · $77.50 ·
Open Payments source
2025-09-18 · Pacira Pharmaceuticals Incorporated · $2,635.00 ·
Open Payments source
2025-09-19 · Pacira Pharmaceuticals Incorporated · $26.11 ·
Open Payments source
2025-09-19 · Pacira Pharmaceuticals Incorporated · $146.17 ·
Open Payments source
2025-09-19 · Pacira Pharmaceuticals Incorporated · $395.70 ·
Open Payments source
2025-09-19 · Pacira Pharmaceuticals Incorporated · $40.00 ·
Open Payments source
2025-09-19 · Pacira Pharmaceuticals Incorporated · $903.97 ·
Open Payments source
2025-09-20 · Pacira Pharmaceuticals Incorporated · $60.33 ·
Open Payments source
2025-09-20 · Pacira Pharmaceuticals Incorporated · $50.06 ·
Open Payments source
2025-09-21 · Pacira Pharmaceuticals Incorporated · $50.78 ·
Open Payments source
2025-09-23 · Pacira Pharmaceuticals Incorporated · $203.14 ·
Open Payments source
2025-09-23 · Pacira Pharmaceuticals Incorporated · $27.98 ·
Open Payments source
2025-09-23 · Pacira Pharmaceuticals Incorporated · $18.28 ·
Open Payments source
2025-09-23 · Pacira Pharmaceuticals Incorporated · $10.80 ·
Open Payments source
2025-09-23 · Pacira Pharmaceuticals Incorporated · $620.00 ·
Open Payments source
2025-09-24 · Pacira Pharmaceuticals Incorporated · $102.07 ·
Open Payments source
2025-09-24 · Pacira Pharmaceuticals Incorporated · $331.97 ·
Open Payments source
2025-09-24 · Pacira Pharmaceuticals Incorporated · $55.00 ·
Open Payments source
2025-09-24 · Pacira Pharmaceuticals Incorporated · $111.25 ·
Open Payments source
2025-09-24 · Pacira Pharmaceuticals Incorporated · $131.50 ·
Open Payments source
2025-09-25 · Pacira Pharmaceuticals Incorporated · $13.66 ·
Open Payments source
2025-09-25 · Pacira Pharmaceuticals Incorporated · $11.63 ·
Open Payments source
2025-09-25 · Pacira Pharmaceuticals Incorporated · $16.73 ·
Open Payments source
2025-09-25 · Pacira Pharmaceuticals Incorporated · $12.82 ·
Open Payments source
2025-09-25 · Pacira Pharmaceuticals Incorporated · $13.29 ·
Open Payments source
2025-09-25 · Pacira Pharmaceuticals Incorporated · $25.60 ·
Open Payments source
2025-09-25 · Pacira Pharmaceuticals Incorporated · $22.71 ·
Open Payments source
2025-09-25 · Pacira Pharmaceuticals Incorporated · $40.00 ·
Open Payments source
2025-09-25 · Pacira Pharmaceuticals Incorporated · $44.28 ·
Open Payments source
2025-09-25 · Pacira Pharmaceuticals Incorporated · $19.92 ·
Open Payments source
2025-10-02 · Pacira Pharmaceuticals Incorporated · $1,550.00 ·
Open Payments source
2025-10-04 · Pacira Pharmaceuticals Incorporated · $109.19 ·
Open Payments source
2025-10-10 · Pacira Pharmaceuticals Incorporated · $86.12 ·
Open Payments source
2025-10-11 · Pacira Pharmaceuticals Incorporated · $32.42 ·
Open Payments source
2025-10-11 · Pacira Pharmaceuticals Incorporated · $864.13 ·
Open Payments source
2025-10-11 · Pacira Pharmaceuticals Incorporated · $21.23 ·
Open Payments source
2025-10-11 · Pacira Pharmaceuticals Incorporated · $433.20 ·
Open Payments source
2025-10-16 · Pacira Pharmaceuticals Incorporated · $2,635.00 ·
Open Payments source
2025-10-16 · Pacira Pharmaceuticals Incorporated · $676.98 ·
Open Payments source
2025-10-16 · Pacira Pharmaceuticals Incorporated · $12.43 ·
Open Payments source
2025-10-16 · Pacira Pharmaceuticals Incorporated · $11.87 ·
Open Payments source
2025-10-16 · Pacira Pharmaceuticals Incorporated · $10.78 ·
Open Payments source
2025-10-16 · Pacira Pharmaceuticals Incorporated · $65.38 ·
Open Payments source
2025-10-16 · Pacira Pharmaceuticals Incorporated · $30.00 ·
Open Payments source
2025-10-16 · Pacira Pharmaceuticals Incorporated · $1,860.00 ·
Open Payments source
2025-10-16 · Pacira Pharmaceuticals Incorporated · $22.94 ·
Open Payments source
2025-10-21 · Pacira Pharmaceuticals Incorporated · $186.00 ·
Open Payments source
2025-10-21 · Pacira Pharmaceuticals Incorporated · $3,100.00 ·
Open Payments source
2025-10-21 · Pacira Pharmaceuticals Incorporated · $1,550.00 ·
Open Payments source
2025-10-22 · Pacira Pharmaceuticals Incorporated · $122.67 ·
Open Payments source
2025-10-23 · Pacira Pharmaceuticals Incorporated · $40.32 ·
Open Payments source
2025-10-23 · Pacira Pharmaceuticals Incorporated · $111.05 ·
Open Payments source
2025-10-23 · Pacira Pharmaceuticals Incorporated · $66.36 ·
Open Payments source
2025-10-23 · Pacira Pharmaceuticals Incorporated · $30.00 ·
Open Payments source
2025-10-23 · Pacira Pharmaceuticals Incorporated · $27.20 ·
Open Payments source
2025-10-23 · Pacira Pharmaceuticals Incorporated · $125.90 ·
Open Payments source
2025-10-23 · Pacira Pharmaceuticals Incorporated · $22.53 ·
Open Payments source
2025-10-23 · Pacira Pharmaceuticals Incorporated · $17.97 ·
Open Payments source
2025-10-23 · Pacira Pharmaceuticals Incorporated · $25.96 ·
Open Payments source
2025-10-24 · Pacira Pharmaceuticals Incorporated · $42.01 ·
Open Payments source
2025-10-25 · Pacira Pharmaceuticals Incorporated · $62.93 ·
Open Payments source
2025-10-28 · Pacira Pharmaceuticals Incorporated · $39.02 ·
Open Payments source
2025-10-28 · Pacira Pharmaceuticals Incorporated · $90.00 ·
Open Payments source
2025-10-28 · Pacira Pharmaceuticals Incorporated · $1,139.46 ·
Open Payments source
2025-10-28 · Pacira Pharmaceuticals Incorporated · $26.88 ·
Open Payments source
2025-10-28 · Pacira Pharmaceuticals Incorporated · $68.18 ·
Open Payments source
2025-10-28 · Pacira Pharmaceuticals Incorporated · $81.32 ·
Open Payments source
2025-10-28 · Pacira Pharmaceuticals Incorporated · $21.98 ·
Open Payments source
2025-10-28 · Pacira Pharmaceuticals Incorporated · $34.68 ·
Open Payments source
2025-10-28 · Pacira Pharmaceuticals Incorporated · $52.21 ·
Open Payments source
2025-10-28 · Pacira Pharmaceuticals Incorporated · $7.99 ·
Open Payments source
2025-10-28 · Pacira Pharmaceuticals Incorporated · $300.00 ·
Open Payments source
2025-10-31 · Pacira Pharmaceuticals Incorporated · $61.08 ·
Open Payments source
2025-10-31 · Pacira Pharmaceuticals Incorporated · $132.80 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $60.00 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $26.67 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $332.13 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $30.25 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $65.38 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $17.51 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $25.06 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $63.98 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $24.47 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $40.00 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $62.57 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $7.67 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $21.14 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $24.61 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $491.97 ·
Open Payments source
2025-11-01 · Pacira Pharmaceuticals Incorporated · $16.16 ·
Open Payments source
2025-11-05 · Pacira Pharmaceuticals Incorporated · $25.24 ·
Open Payments source
2025-11-05 · Pacira Pharmaceuticals Incorporated · $3,100.00 ·
Open Payments source
2025-11-05 · Pacira Pharmaceuticals Incorporated · $34.48 ·
Open Payments source
2025-11-05 · Pacira Pharmaceuticals Incorporated · $66.36 ·
Open Payments source
2025-11-05 · Pacira Pharmaceuticals Incorporated · $7.11 ·
Open Payments source
2025-11-05 · Pacira Pharmaceuticals Incorporated · $60.00 ·
Open Payments source
2025-11-13 · Pacira Pharmaceuticals Incorporated · $217.00 ·
Open Payments source
2025-11-13 · Pacira Pharmaceuticals Incorporated · $3,875.00 ·
Open Payments source
2025-11-25 · Pacira Pharmaceuticals Incorporated · $1,860.00 ·
Open Payments source
2025-12-05 · Pacira Pharmaceuticals Incorporated · $54.08 ·
Open Payments source
2025-12-05 · Pacira Pharmaceuticals Incorporated · $300.00 ·
Open Payments source
2025-12-06 · Pacira Pharmaceuticals Incorporated · $194.43 ·
Open Payments source
2025-12-06 · Pacira Pharmaceuticals Incorporated · $137.77 ·
Open Payments source
2025-12-06 · Pacira Pharmaceuticals Incorporated · $194.43 ·
Open Payments source
2025-12-06 · Pacira Pharmaceuticals Incorporated · $34.23 ·
Open Payments source
2025-12-06 · Pacira Pharmaceuticals Incorporated · $40.00 ·
Open Payments source
2025-12-06 · Pacira Pharmaceuticals Incorporated · $573.96 ·
Open Payments source
2025-12-06 · Pacira Pharmaceuticals Incorporated · $20.65 ·
Open Payments source
2025-12-06 · Pacira Pharmaceuticals Incorporated · $22.59 ·
Open Payments source
2025-12-06 · Pacira Pharmaceuticals Incorporated · $136.95 ·
Open Payments source
2025-12-07 · Pacira Pharmaceuticals Incorporated · $4.63 ·
Open Payments source
2025-12-07 · Pacira Pharmaceuticals Incorporated · $19.15 ·
Open Payments source
2025-12-07 · Pacira Pharmaceuticals Incorporated · $83.33 ·
Open Payments source
2025-12-07 · Pacira Pharmaceuticals Incorporated · $11.30 ·
Open Payments source
2025-12-07 · Pacira Pharmaceuticals Incorporated · $187.50 ·
Open Payments source
2025-12-07 · Pacira Pharmaceuticals Incorporated · $24.31 ·
Open Payments source
2025-12-11 · Pacira Pharmaceuticals Incorporated · $27.41 ·
Open Payments source
2025-12-17 · Pacira Pharmaceuticals Incorporated · $26.43 ·
Open Payments source
2025-12-18 · Pacira Pharmaceuticals Incorporated · $48.49 ·
Open Payments source
2025-12-18 · Pacira Pharmaceuticals Incorporated · $8.08 ·
Open Payments source
2025-12-18 · Pacira Pharmaceuticals Incorporated · $32.45 ·
Open Payments source
2025-12-18 · Pacira Pharmaceuticals Incorporated · $19.40 ·
Open Payments source
2025-12-18 · Pacira Pharmaceuticals Incorporated · $65.80 ·
Open Payments source
2025-12-18 · Pacira Pharmaceuticals Incorporated · $27.42 ·
Open Payments source
2025-12-18 · Pacira Pharmaceuticals Incorporated · $90.00 ·
Open Payments source
2025-12-18 · Pacira Pharmaceuticals Incorporated · $24.06 ·
Open Payments source
2025-12-18 · Pacira Pharmaceuticals Incorporated · $6.47 ·
Open Payments source
2025-12-18 · Pacira Pharmaceuticals Incorporated · $1,550.00 ·
Open Payments source
2025-12-22 · Pacira Pharmaceuticals Incorporated · $4,960.00 ·
Open Payments source
2025-12-23 · Pacira Pharmaceuticals Incorporated · $15.84 ·
Open Payments source
Zilretta Normalized: zilretta Drug
Pacira Pharmaceuticals Incorporated
$22,119.13
49
2025
Source payment records
Exparel Normalized: exparel Drug
Pacira Pharmaceuticals Incorporated
$14,776.53
34
2025
Source payment records
COOLIEF COOLED RADIOFREQUENCY Normalized: coolief cooled radiofrequency Device
Avanos Medical
$157.09
2
2025
Source payment records
XCELL Normalized: xcell Device
Bioventus LLC
$101.23
3
2025
Source payment records
JOURNAVX Normalized: journavx Drug
VERTEX PHARMACEUTICALS INCORPORATED
$83.09
3
2025
Source payment records
ETERNA Normalized: eterna Device
Abbott Laboratories
$71.47
1
2025
Source payment records
BOTOX Normalized: botox Biological
ABBVIE INC.
$30.84
1
2025
Source payment records
EXOGEN ULTRASOUND BONE HEALING SYSTEM Normalized: exogen ultrasound bone healing system Device
Bioventus LLC
$28.39
1
2025
Source payment records
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
Brand Generic Claims Beneficiaries
Gabapentin Gabapentin 53 30 Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen 45 37 Diazepam Diazepam 43 34 Tramadol Hcl Tramadol Hcl 20 12 Meloxicam Meloxicam 12 suppressed Methocarbamol Methocarbamol 11 suppressed Tizanidine Hcl Tizanidine Hcl 11 suppressed
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
Year General Payments Main payer Explicit products Company overlaps Part D coverage
2025
$75,081.83 · 239 records
Pacira Pharmaceuticals Incorporated
BOTOX, COOLIEF COOLED RADIOFREQUENCY, ETERNA, EXOGEN ULTRASOUND BONE HEALING SYSTEM, Exparel, Iovera, JOURNAVX, XCELL, Zilretta
—
—
2024
—
—
—
—
Complete
Questions to ask
Questions you could discuss with your doctor
Are there reasonable alternatives I should understand when we discuss treatment options? How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
Dataset Year Publication Source
CMS Open Payments — General Payments
2025
2026-06-30
Original source
Medicare Part D Prescribers by Provider and Drug
2024
2026-05-06
Original source
NPPES Data Dissemination V2
current / reference data
2026-08-10
Original source
Full methodology · Questions & answers · Report a possible error